Reaction
Acute Myeloid Leukaemia Refractory reporting signals
As of the last recalculation, Acute Myeloid Leukaemia Refractory appears in 166 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE FOR (PRR 507.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Azacitidine For | 51 | 507.0 | 508.5 |
| Azacitidine | 57 | 366.3 | 367.0 |
| Venetoclax | 72 | 258.1 | 258.4 |
| Posaconazole Delayed-Release | 12 | 147.6 | 147.8 |
| Posaconazole | 13 | 108.8 | 108.8 |
| Fludarabine Phosphate | 24 | 89.3 | 89.3 |
| Thiotepa | 6 | 81.7 | 81.7 |
| Busulfan | 8 | 66.9 | 67.0 |